Comment from American Association of Pharmaceutical Scientists (AAPS)

Summary: The American Association of Pharmaceutical Scientists (AAPS) supports the draft guidance but requests specific clarifications and additions. They advocate for clearer language on early engagement with the FDA, explicit references to reporting standards, and better recognition of how in vitro data supports quantitative translational modeling and model-informed decision-making.